Gaurav Vij

Background

About Gaurav Vij

Disciplined and results-driven biopharma executive with significant experience in corporate development, strategy, and commercial operations across multiple therapeutics e.g, Oncology, Cell Therapy, Ophthalmology, & Rare diseases. Track record of negotiating and closing diverse domestic and international M&A and licensing transactions from cradle to grave. Sales & Mktg. leader with experience launching instruments/devices in life sciences space. Demonstrated ability to formulate strategies, launch new products, create new business units/product lines, lead cross-functional teams in sourcing external innovation and driving strong business performance. Self-starter with exceptional communication finesse and ability to work in unstructured and fast-paced environments. Highly networked individual with deep & broad connections in biopharma industry. Experienced in raising seed & series A funding for biotech’s. Notable Accomplishments-$10.4B acquisition of Onyx Pharma (oncology)-$4.9B M&A Forty-Seven Inc (oncology)-$415M acquisition of deCODE Genetics (human genetics platform)- Divested large biologics manufacturing plant to cut operating costs by ~$50M/yr. & saved ~200 jobs Therapeutics / Platforms Experience: Cell Therapy, Rare Diseases, Oncology, Inflammation, Respiratory, Ophthalmology and Glaucoma Drug Delivery. Medical Devices, Manufacturing Instruments Skills: Licensing/M&A, Deal Sourcing, Due Diligence, Negotiations, Term Sheet, Valuation, Commercial Forecast, Deal Structuring, Mkt. Research, Analytics, Project Management, Legal/Tax Issues, Deal Databases, Problem Solver & Entrepreneurial, Sales & Mktg. Commercial Ops, Cost Management & Sales Growth